Target intelligence / Profile preview

Vibrio parahaemolyticus (V. parahaemolyticus)

Target
V. parahaemolyticus
Molecular classification
Gram-negative bacterium, Pathogen
01

Overview

Vibrio parahaemolyticus is a Gram-negative, halophilic, curved rod-shaped bacterium that naturally inhabits coastal and estuarine waters (StatPearls, 2023). It is recognized as a major cause of foodborne gastroenteritis worldwide, primarily associated with the consumption of raw or undercooked seafood, particularly oysters (CDC, 2019). The pathogenicity of V. parahaemolyticus is largely attributed to its production of virulence factors such as thermostable direct hemolysin (TDH) and TDH-related hemolysin (TRH), which disrupt host cell membranes and induce fluid secretion in the intestines (PubMed, 2021). While most infections are self-limiting and present as watery diarrhea, the organism can also cause severe necrotizing wound infections and primary septicemia, especially in immunocompromised individuals or those with underlying liver disease (NIH, 2022). Therapeutic intervention typically focuses on oral rehydration, but severe or systemic cases require antibiotics such as doxycycline or ciprofloxacin to inhibit bacterial replication and protein synthesis (StatPearls, 2023).

Other names
V. parahaemolyticusVibrio parahemolyticus
02

Mechanism of action

Antibiotics targeting this organism act by inhibiting bacterial protein synthesis (e.g., tetracyclines and macrolides), DNA gyrase and topoisomerase IV (e.g., fluoroquinolones), or cell wall synthesis (e.g., cephalosporins) (StatPearls, 2023).

03

Biological functions

PathogenesisToxin productionBiofilm formationHalophilic adaptationCytotoxicity
04

Disease associations

InfectionGastroenteritisSepticemiaWound infection
05

Safety considerations

Antibiotic resistance (intrinsic resistance to ampicillin is common)Risk of fatal septicemia in patients with chronic liver disease or iron overloadRapid progression of necrotizing fasciitis in wound infections
06

Interacting drugs

Doxycycline

5 more in the full profile.

07

Biomarkers

Thermostable direct hemolysin (TDH)TDH-related hemolysin (TRH)tlh geneType III secretion systems (T3SS1 and T3SS2)

Beyond the preview

Go deeper on Vibrio parahaemolyticus (V. parahaemolyticus).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vibrio parahaemolyticus (V. parahaemolyticus).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call